| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.001 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.002 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |